Loading…
Partnership aims to tap into the trillion-dollar cellular rejuvenation market.
Visionary Holdings Inc. (Nasdaq: GV) announced a strategic alliance with Yike Regenerative Medicine to unlock the trillion-dollar cellular rejuvenation and aesthetic treatment market. The partnership aims to leverage Yike's expertise in regenerative medicine and Visionary Holdings' educational services to create innovative solutions in the cellular rejuvenation space.
The collaboration will focus on developing and commercializing new treatments and therapies that address the growing demand for aesthetic and regenerative medicine solutions. The companies will work together to bring these innovations to market, targeting a broad range of consumers seeking advanced cellular rejuvenation options.
Visionary Holdings Inc. has a free float of 1,678,400 shares and 4,090,700 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.